Colon News and Research

RSS

New health system scorecard reveals wide health gaps among states

States made little progress in improving health care access, quality, and outcomes and lowering costs in the five years preceding implementation of the major coverage provisions of the Affordable Care Act (2007-2012), according to the Commonwealth Fund's third state health system scorecard. The majority of states declined or failed to improve on two-thirds of the 34 scorecard indicators that could be tracked over time.

30 Apr 2014

Researchers develop new strategy to personalised medicine in advanced cancer patients

Tumour cells can accumulate hundreds or even thousands of DNA mutations which induce the growth and spread of cancer. The number and pattern of mutations differs according to the type of tumour, even among those that are classified as part of the same type of tumours.

30 Apr 2014

Two internationally known scholars join Huntsman Cancer Institute

Two internationally known scholars, one in the field of cancer prevention and the other in the field of molecular biology, will join Huntsman Cancer Institute (HCI) at the University of Utah as early as Sept. 1.

29 Apr 2014

Promising new approach targets cancer protein to slow tumor growth

Sometimes a full-on assault isn't the best approach when dealing with a powerful enemy. A more effective approach, in the long run, may be to target the support system replenishing the supplies that keep your foe strong and ready for battle.

26 Apr 2014

AGA Research Foundation announces 2014 AGA Research Scholars

The American Gastroenterological Association Research Foundation is pleased to announce the 2014 AGA Research Scholars. The AGA Research Scholar Awards program, launched in 1984, enables young investigators to develop independent and productive research careers in digestive diseases. This year, the AGA Research Scholar Awards fund an additional year allowing for three consecutive years of funding.

25 Apr 2014

Aspirin can lower colon cancer risk among people with high levels of specific gene

The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene.

25 Apr 2014

Studies identify 2 genes highly associated with IBD

Inflammatory Bowel Disease (IBD), a group of chronic inflammatory disorders of the intestine that result in painful and debilitating complications, affects over 1.4 million people in the U.S., and while there are treatments to reduce inflammation for patients, there is no cure.

23 Apr 2014

FDA approves Cyramza to treat patients with advanced stomach cancer

Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.

22 Apr 2014

New genetic evidence strengthens link between role of dietary fats with colon cancer progression

Scientists have shown new genetic evidence that could strengthen the link between the role of dietary fats with colon cancer progression.

22 Apr 2014

FDA approves molecularly targeted drug as second-line treatment for advanced stomach cancer

Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.

22 Apr 2014

Researchers develop simple assay that reveals evolutionary relationships among various tumor sites within patient

The process of metastasis - a tumor's ability to spread to other parts of the body - is still poorly understood. It is not easy to determine whether metastasis began early or late in the development of the primary tumor or whether individual metastatic sites were seeded directly from the original tumor or from an intermediate site.

22 Apr 2014

Researchers recommend early colorectal cancer screening guidelines for cervical cancer survivors

Researchers at the University of Texas Medical Branch at Galveston are the first to recommend that young women treated with radiation for cervical cancer should begin colorectal cancer screening earlier than traditionally recommended.

17 Apr 2014

Study quantifies adherence to recommended surveillance colonoscopy in average-risk patients

According to a new study, endoscopists' recommendations for timing of surveillance colonoscopy in average-risk patients with one to two small polyps are consistent with guideline recommendations in about 90 percent of cases. T

17 Apr 2014

TGen honors two philanthropists for supporting TGen's research on brain, colon and prostate cancer

The Translational Genomics Research Institute (TGen) recently honored two significant Arizona philanthropists at their annual Founders Dinner for their support of TGen's research into brain, colon and prostate cancer. The event took place March 28 in Scottsdale.

17 Apr 2014

Daylight Medical releases SKY 6Xi disinfection technology for mobile devices

Daylight Medical, manufacturer and provider of innovative medical products, is pleased to announce its rollout of SKY 6Xi, disinfection technology for mobile devices. SKY 6Xi uses high intensity (254 nanometer wavelength) ultraviolet light in the "C" spectrum (UVC) at close proximity to thoroughly disinfect a mobile device. The unique power of SKY reduces the risk that Hospital-acquired infections (HAIs) are transmitted to patients while improving safety for healthcare workers.

15 Apr 2014

Effects of PectaSol-C modified citrus pectin in prostate cancer patients to be studied in phase III trial

A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now recruiting participants to study the effects of dietary supplement PectaSol-C modified citrus pectin (MCP) in controlling prostate specific antigen (PSA) levels in prostate cancer patients.

15 Apr 2014

Vivolux receives FDA clearance to proceed with phase I/II clinical trial of VLX600

Vivolux AB, a drug discovery company specialized in cancer treatment, announced today that the FDA has granted clearance to proceed with VLX600 into the clinical phase I/II. VLX600 is one of the company's promising projects, and which was recently published in the journal Nature Communications.

15 Apr 2014

New data shows that gut microbiota has potential role in development of ALD

Exciting new data presented today at the International Liver Congress- 2014 shows that the gut microbiota has a potential role in the development of alcoholic liver disease (ALD).

15 Apr 2014

1/4 human tumor exist genetic polymorphisms linked with increased risk of cancer

In 10% of human tumors there is a family history of hereditary disease associated with mutations in identified genes. The best examples are the cases of polyps in the large intestine associated with the APC gene and breast cancer associated with BRCA1 and BRCA2 genes.

11 Apr 2014

Study: Honokiol reduces proliferation of renal cell carcinoma

A new study shows that honokiol, a small molecule polyphenol extract derived from Magnolia officinalis bark, reduces proliferation of renal cell carcinoma.

9 Apr 2014

Colon News and Research

New health system scorecard reveals wide health gaps among states

Researchers develop new strategy to personalised medicine in advanced cancer patients

Two internationally known scholars join Huntsman Cancer Institute

Promising new approach targets cancer protein to slow tumor growth

AGA Research Foundation announces 2014 AGA Research Scholars

Aspirin can lower colon cancer risk among people with high levels of specific gene

Studies identify 2 genes highly associated with IBD

FDA approves Cyramza to treat patients with advanced stomach cancer

New genetic evidence strengthens link between role of dietary fats with colon cancer progression

FDA approves molecularly targeted drug as second-line treatment for advanced stomach cancer

Researchers develop simple assay that reveals evolutionary relationships among various tumor sites within patient

Researchers recommend early colorectal cancer screening guidelines for cervical cancer survivors

Study quantifies adherence to recommended surveillance colonoscopy in average-risk patients

TGen honors two philanthropists for supporting TGen's research on brain, colon and prostate cancer

Daylight Medical releases SKY 6Xi disinfection technology for mobile devices

Effects of PectaSol-C modified citrus pectin in prostate cancer patients to be studied in phase III trial

Vivolux receives FDA clearance to proceed with phase I/II clinical trial of VLX600

New data shows that gut microbiota has potential role in development of ALD

1/4 human tumor exist genetic polymorphisms linked with increased risk of cancer

Study: Honokiol reduces proliferation of renal cell carcinoma

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News